Stefan Eriksson

Stefan Eriksson discloses dealings in BioInvent International AB to Finansinspektionen. In total, 3 filings cover trades dated from 12 April 2019 to 27 June 2022.

Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

Most recently, on 27 June 2022, the filings show a transaction in BioInvent International AB. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, MAR article 19 gives managers three business days to notify a trade. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.